Showing results (51-60 of 284) with videos related to
Sort By:
Pageof 29
The Journal of Experimental Medicine|June 1, 1995
Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte linesB Fisk, T L Blevins, J T Wharton, et al.Obstetrics and Gynecology|April 1, 1975
Treatment of clear cell adenocarcinoma in young femalesJ T Wharton, F N Rutledge, H S Gallager, et al.International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervixP J Eifel, M Morris, J T Wharton, et al.Cancer Clinical Trials|January 1, 1980
Single-agent chemotherapy for recurrent carcinoma of the cervixR S Freedman, J Herson, J T Wharton, et al.Obstetrics and Gynecology|March 1, 1984
Intrapartum maternal lumbosacral plexopathyB Gonik, C A Stringer, D B Cotton, et al.Obstetrics and Gynecology|July 1, 1984
Fetal growth sustained by parenteral nutrition in pregnancyM E Rivera-Alsina, L R Saldana, C A StringerJournal of Biological Response Modifiers|January 1, 1983
Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinomaR S Freedman, J U Gutterman, J T Wharton, et al.American Journal of Obstetrics and Gynecology|May 1, 1975
Adenocarcinoma of the uterine cervixF N Rutledge, A E Galakatos, J T Wharton, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1987
Palliative radiotherapy for ovarian cancerM D Adelson, J T Wharton, L Delclos, et al.International Journal of Radiation Oncology, Biology, Physics|April 1, 1988
Safety of adjunctive transvaginal beam therapy in the treatment of squamous cell carcinoma of the uterine cervixM J Seider, L J Peters, J T Wharton, et al.Pageof 29